Immunoprecise Antibodies Ltd
XTSX:IPA
Immunoprecise Antibodies Ltd
XTSX:IPA
Price:
6.5 CAD
0.78%
Updated:
May 10, 2024
Immunoprecise Antibodies Ltd
Tax Provision
|
Immunoprecise Antibodies Ltd
Tax Provision Peer Comparison
Comparables:
ABCL
ARCH
RP
IOT
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Immunoprecise Antibodies Ltd
XTSX:IPA
|
Tax Provision
-CA$1.3m
|
CAGR 3-Years
-130%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Tax Provision
$27.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Arch Biopartners Inc
XTSX:ARCH
|
Tax Provision
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Tax Provision
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovotech Inc
XTSX:IOT
|
Tax Provision
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Immunoprecise Antibodies Ltd's Tax Provision?
Tax Provision
-1.3m
CAD
-1.3m
CAD
Based on the financial report for Apr 30, 2021, Immunoprecise Antibodies Ltd's Tax Provision amounts to -1.3m CAD.
What is Immunoprecise Antibodies Ltd's Tax Provision growth rate?
Tax Provision CAGR 3Y
-130%
-130%
The average annual Tax Provision growth rates for Immunoprecise Antibodies Ltd have been -130% over the past three years .
You don't have any saved screeners yet
